naloxone hydrochloride
Generic: naloxone hydrochloride
Labeler: mylan institutional llcDrug Facts
Product Profile
Brand Name
naloxone hydrochloride
Generic Name
naloxone hydrochloride
Labeler
mylan institutional llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
naloxone hydrochloride .4 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
67457-987
Product ID
67457-987_4f711224-09e7-4c4e-8780-e7e76c572f8c
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA205014
Listing Expiration
2026-12-31
Marketing Start
2019-11-20
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
67457987
Hyphenated Format
67457-987
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
naloxone hydrochloride (source: ndc)
Generic Name
naloxone hydrochloride (source: ndc)
Application Number
ANDA205014 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .4 mg/mL
Packaging
- 10 VIAL, MULTI-DOSE in 1 CARTON (67457-987-10) / 10 mL in 1 VIAL, MULTI-DOSE (67457-987-00)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "4f711224-09e7-4c4e-8780-e7e76c572f8c", "openfda": {"unii": ["F850569PQR"], "rxcui": ["1191222"], "spl_set_id": ["8eb8cb6a-8e50-4f22-a516-6831552baa0d"], "manufacturer_name": ["Mylan Institutional LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, MULTI-DOSE in 1 CARTON (67457-987-10) / 10 mL in 1 VIAL, MULTI-DOSE (67457-987-00)", "package_ndc": "67457-987-10", "marketing_start_date": "20191120"}], "brand_name": "Naloxone Hydrochloride", "product_id": "67457-987_4f711224-09e7-4c4e-8780-e7e76c572f8c", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "67457-987", "generic_name": "naloxone hydrochloride", "labeler_name": "Mylan Institutional LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naloxone Hydrochloride", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".4 mg/mL"}], "application_number": "ANDA205014", "marketing_category": "ANDA", "marketing_start_date": "20191120", "listing_expiration_date": "20261231"}